Surface Oncology Inc (SURF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2017 | 03-2017 | 12-2016 | 03-2016 | 12-2015 | |
| Sales | 12,826 | 0 | 6,632 | 0 | 6,632 |
| Gross Profit | 12,826 | 1,670 | 6,632 | 0 | 6,632 |
| Operating Expenses | 58,816 | 11,033 | 24,636 | 4,144 | 4,144 |
| Operating Income | -45,990 | -11,033 | -18,004 | -4,144 | 2,488 |
| Other Income | 613 | 613 | 551 | 551 | -19,941 |
| Pre-tax Income | -45,377 | -10,420 | -17,453 | -3,593 | -17,453 |
| Income Tax | N/A | 210 | N/A | 0 | N/A |
| Net Income Continuous | -45,377 | -10,630 | -17,453 | -3,593 | -17,453 |
| Net Income | $-45,377 | $-45,377 | $-17,453 | $-17,453 | $-17,453 |
| EPS Basic Total Ops | -18.35 | N/A | -7.31 | N/A | N/A |
| EPS Basic Continuous Ops | -18.33 | N/A | -7.29 | N/A | N/A |
| EPS Diluted Total Ops | -18.35 | N/A | -7.31 | N/A | N/A |
| EPS Diluted Continuous Ops | -18.33 | N/A | -7.29 | N/A | N/A |
| EBITDA(a) | $-44,510 | $-10,713 | $-17,196 | $-4,144 | $2,488 |